- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Triple-hit DLBCL
Total 574 results
-
Zhao WeiliNot yet recruitingDiffuse Large B-cell LymphomaChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingDiffuse Large B-Cell LymphomaChina
-
Ruijin HospitalNot yet recruitingDiffuse Large B Cell Lymphoma
-
Ruijin HospitalRecruitingLymphoma | DLBCL | T Cell LymphomaChina
-
Technische Universität DresdenGerman Cancer Research CenterRecruitingNeoplasms | Multiple Myeloma in Relapse | Multiple Myeloma, Refractory | Relapsed Diffuse Large B-cell Lymphoma (DLBCL) | Refractory Diffuse Large B-cell Lymphoma (DLBCL)Germany
-
Peking University People's HospitalPeking University Cancer Hospital & InstituteRecruiting
-
BeiGeneRecruitingRefractory Chronic Lymphocytic Leukemia | Refractory Non-Hodgkin Lymphoma | Relapsed Follicular Lymphoma | Refractory Small Lymphocytic Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Refractory Diffuse Large B-cell Lymphoma | Transformed Non-Hodgkin Lymphoma | Relapsed... and other conditionsChina, Australia
-
ImmPACT BioRecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
The First Affiliated Hospital of Soochow UniversityRecruitingDiffuse Large B-Cell LymphomaChina
-
Chinese PLA General HospitalRecruitingDiffuse Large B Cell Lymphoma | Central Nervous System Lymphoma | Extranodal Extension | Relapse/RecurrenceChina
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingDiffuse Large B-cell Lymphoma
-
Accutar Biotechnology IncRecruitingRelapsed/Refractory B-cell MalignanciesUnited States
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingDiffuse Large B-cell Lymphoma
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte CorporationRecruitingDiffuse Large B Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterTakedaRecruitingB-Cell Lymphoma | Large B-cell Lymphoma | DLBCL, Nos Genetic Subtypes | Mediastinal Large B-cell Lymphoma | High-grade B Cell LymphomaUnited States
-
AbbVieRecruitingHematologic CancerUnited States, Israel, Japan
-
Fondazione Policlinico Universitario Agostino Gemelli...Istituti Fisioterapici Ospitalieri; Istituto Nazionale Tumori IRCCS - Fondazione...Not yet recruitingDiffuse Large B Cell Lymphoma | Relapsed Non-Hodgkin LymphomaItaly
-
Byondis B.V.RecruitingLymphomaSpain, United Kingdom, Netherlands, Italy
-
MingSight Pharmaceuticals, IncShenzhen MingSight Relin Pharmaceutical Co., LtdRecruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Relapsed or Refractory B-cell Lymphoma | Marginal Zone Lymphoma (MZL)China
-
Anhui Provincial HospitalLeman Biotech Co., LtdRecruitingDiffuse Large B-cell LymphomaChina
-
Nektar TherapeuticsRecruitingNon-Hodgkin Lymphoma | Relapsed/Refractory Diffuse Large B-cell LymphomaUnited States
-
ADC Therapeutics S.A.RecruitingDiffuse Large B-Cell Lymphoma | High-grade B-cell LymphomaTaiwan, Korea, Republic of, United States, Brazil
-
Ningbo No. 1 HospitalZhejiang UniversityRecruitingDiffuse Large B-cell LymphomaChina
-
Mitsubishi Tanabe Pharma CorporationRecruiting
-
Acepodia Biotech, Inc.RecruitingFollicular Lymphoma | B-cell Lymphoma | Marginal Zone Lymphoma | Non Hodgkin Lymphoma | DLBCL | Primary Mediastinal Large B Cell LymphomaUnited States, Taiwan
-
University Medical Center GroningenStichting Hemato-Oncologie voor Volwassenen NederlandRecruitingNHL | DLBCL - Diffuse Large B Cell LymphomaNetherlands
-
PfizerIncyte Corporation; MorphoSys AGRecruitingDiffuse Large B-Cell LymphomaUnited States, Japan, Puerto Rico, Korea, Republic of
-
University of NebraskaBristol-Myers SquibbRecruitingFollicular Lymphoma | Refractory Non-Hodgkin Lymphoma | High-grade B-cell Lymphoma | DLBCL - Diffuse Large B Cell Lymphoma | Relapsed Non-Hodgkin Lymphoma | Mediastinal Large B-cell Lymphoma | Indolent B-Cell Non-Hodgkin LymphomaUnited States
-
LanZhou UniversityBeigene (Beijing) Biotechnology Co., LtdNot yet recruitingDiffuse Large B-cell Lymphoma (DLBCL)China
-
Patrick C. Johnson, MDAstraZenecaRecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Diffuse Large B-cell Lymphoma (DLBCL) | Grade 3b Follicular Lymphoma | Refractory Aggressive B-cell Lymphomas | Aggressive B-cell NHL | De Novo or Transformed Indolent B-cell Lymphoma | DLBCL, Nos Genetic Subtypes | T Cell/Histiocyte-rich Large B-cell Lymphoma and other conditionsUnited States
-
Sun Yat-sen UniversityFudan University; Antengene CorporationRecruitingEBV-Positive Diffuse Large B-Cell Lymphoma, NosChina
-
GenmabAbbVieRecruitingDiffuse Large B-Cell LymphomaKorea, Republic of, Spain, Japan, Israel, Australia, Poland, Netherlands, Sweden, Greece, Taiwan, Italy, Denmark, Switzerland, France, Bulgaria, Hungary, Austria, New Zealand, Czechia, Croatia, Belgium, Brazil, China, United States, Canada and more
-
Jianfeng ZhouCSPC Ouyi Pharmaceutical Co., Ltd.Not yet recruiting
-
Chengdu Zenitar Biomedical Technology Co., LtdRecruitingStudy of Purinostat Mesylate for Injection in the Treatment of Diffuse Large B-cell Lymphoma (DLBCL)Diffuse Large B Cell Lymphoma,DLBCLChina
-
Beijing InnoCare Pharma Tech Co., Ltd.Recruiting
-
Monte Rosa Therapeutics, IncRecruitingNSCLC | Prostate Cancer | SCLC | DLBCL | High Grade Neuroendocrine Cancer | L-MYC and N-MYC Amplified Solid Tumors | NSCLC With High or Low L-MYC or N-MYC Expression | HR-positive, HER2-negative Breast CancerUnited States, Canada
-
Schrödinger, Inc.RecruitingFollicular Lymphoma | Splenic Marginal Zone Lymphoma | Burkitt Lymphoma | Plasmablastic Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Lymphoplasmacytic Lymphoma | Non Hodgkin Lymphoma | Primary Effusion Lymphoma | DLBCL | High-grade B-cell Lymphoma | Primary Mediastinal... and other conditionsUnited States, Moldova, Republic of
-
Novartis PharmaceuticalsRecruitingFollicular Lymphoma | Acute Lymphoblastic Leukemia | Diffuse Large B-cell LymphomaBrazil
-
Hospices Civils de LyonNot yet recruitingDiffuse Large B-cell Lymphoma (DLBCL) | CAR-T Cells TreatmentFrance
-
Peking Union Medical College HospitalRecruitingDiffuse Large B Cell Lymphoma | Radiotherapy | CAR-T | Bridging TherapyChina
-
AbbVieRecruitingFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Chronic Lymphocytic LeukemiaUnited States, Australia, Canada, Israel
-
The Affiliated Hospital of Qingdao UniversityNot yet recruiting
-
The First Affiliated Hospital of Soochow UniversityRecruitingDiffuse Large B-Cell LymphomaChina
-
Ranok Therapeutics (Hangzhou) Co., Ltd.RecruitingAdvanced Solid Tumor | DLBCLUnited States
-
Athenex, Inc.RecruitingB-cell Lymphoma | CLL/SLL | ALL, Childhood | DLBCL - Diffuse Large B Cell Lymphoma | B-cell Leukemia | NHL, Relapsed, Adult | ALL, Adult B CellUnited States
-
Li ZhimingAntengene CorporationRecruitingDLBCL Germinal Center B-Cell TypeChina
-
University Hospital, BonnRecruitingFollicular Lymphoma | Multiple Myeloma | Myocarditis | Cytokine Release Syndrome | DLBCL | MCL | ALL | CAR T-cell Therapy | PCBCLGermany
-
Washington University School of MedicineGenentech, Inc.RecruitingB Cell Lymphoma | Diffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Transformed Lymphoma | Aggressive Lymphoma | Follicular Lymphoma Grade 3United States
-
Merck Sharp & Dohme LLCRecruitingLymphoma, Large B-Cell, Diffuse (DLBCL)Italy, Canada, Israel, Korea, Republic of, Poland, Spain, Turkey
-
Tel-Aviv Sourasky Medical CenterRecruiting